跳至主要内容
临床试验/NCT03710369
NCT03710369已完成不适用

Ergogenic Effect of PDE-5 Inhibitors at Moderate Altitude

University of British Columbia1 个研究点 分布在 1 个国家目标入组 10 人开始时间: 2015年11月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
入组人数
10
试验地点
1
主要终点
Performance in completion of Time Trial task

研究概览

简要总结

The degree to which endurance exercise performance is diminished in acute hypoxia is variable and appears to be the result of several different physiological processes, however this research focuses on hypoxic pulmonary vasoconstriction (HPV). Sildenafil, a pulmonary vasodilator, has been used with mixed results to improve athletic performance in hypoxia. Because sildenafil has been shown to reduce HPV in some individuals, we believe that its effectiveness is closely related to the magnitude of the HPV response and the degree that individual exercise performance declines in hypoxia. This research will investigate the relationship between sildenafil, HPV, and exercise performance.

详细描述

  1. Purpose

The purpose of this research proposal is to evaluate the role of hypoxic pulmonary vasoconstriction (HPV) and the formation of arteriovenous anastomoses (shunts) in hypoxia and their effect on endurance exercise performance. The pulmonary vasodilator sildenafil will be used to reverse the effects of HPV during exercise. Large between-subject variability in exercise performance in hypoxia could be explained by similar variability in the HPV response. Elite and recreational athletes could benefit significantly from being aware of their HPV response to hypoxia and could alter their training accordingly based on this knowledge. The vasodilator sildenafil may provide a level playing field for those athletes who are compromised by a robust HPV response. 2. Hypothesis

A greater decline in exercise performance in acute moderate hypoxia (FIO2 = 0.16) will be correlated with a higher pulmonary artery pressure (PAP) during steady-state exercise and resting in hypoxia, increased arteriovenous anastomoses in hypoxia, and a lower hypoxic ventilatory response (HVR). These subjects will have significantly improved exercise performance in hypoxia with sildenafil administration. This increase in performance will be associated with reduced PAP and increases in cardiac output. 3. Justification

Professional athletic competitions are frequently held at moderate altitude: 1500-2999 meters, or a barometric pressure (PB) of 635-525 mmHg. These competitions include sports such as sky-running competitions and ski randonnée racing as well as Olympic competitions, for example the 1968 Mexico City Olympics, held at an altitude of 2,240 meters.

Reasons for holding a competition at altitude vary. Some event host cities have venues that are situated at moderate altitude. Winter events that require a significant snowpack, such as Nordic and alpine ski races, are routinely held above 1500 meters. Finally, some athletes such as track cyclists and long track speed skaters may seek out moderate altitude venues where decreased atmospheric pressure reduces aerodynamic drag.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Basic Science
盲法
Single (Participant)

入排标准

年龄范围
19 Years 至 40 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • between age 19 (18 if a University of British Columbia student) and 40
  • competitive cyclist (hold current racing license of professional, category 1, or 2 or have a measured VO2max greater than 60 ml.min.kg).

排除标准

  • anyone unable to complete the exercise protocol
  • individuals with a history of cardiovascular or respiratory illness
  • those with an atrial or ventricular septal defect (e.g. patent foramen oval)
  • anyone currently prescribed sildenafil, tadalafil, vardenafil or any other PDE-5 inhibiting medication
  • anyone who has lived more than 15 days at moderate altitude in the last three months

研究组 & 干预措施

Normoxia

Sham Comparator

Exercise in room air (normoxia). Sildenafil

干预措施: Sildenafil (Drug)

Hypoxia

Active Comparator

Exercise in hypoxic air (reduced O2 concentration) that simulates 2500m elevation for 30-40 minutes with Sildenafil. Placebo

干预措施: Placebo (Drug)

Hypoxia

Active Comparator

Exercise in hypoxic air (reduced O2 concentration) that simulates 2500m elevation for 30-40 minutes with Sildenafil. Placebo

干预措施: Sildenafil (Drug)

结局指标

主要结局

Performance in completion of Time Trial task

时间窗: 20 minutes after test.

Performance is measured as the mean power output achieved during the time trial task.

次要结局

  • PAP measured with ultrasound during exercise.(20 minutes after test.)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Michael Koehle

Dr. Michael Koehle

University of British Columbia

研究点 (1)

Loading locations...

相似试验